Procoagulant role of microparticles in routine storage of packed red blood cells: potential risk for prothrombotic post-transfusion complications

Pathology. 2017 Jan;49(1):62-69. doi: 10.1016/j.pathol.2016.10.001. Epub 2016 Nov 26.

Abstract

During routine storage, packed red blood cells (PRBC) undergo biochemical and morphological changes including loss of red blood cell (RBC) membrane asymmetry and release of microparticles (MPs) bearing phosphatidylserine (PS), a procoagulant phospholipid. This study investigated the association between PRBC storage duration, MP profile and procoagulant activity. Leukodepleted PRBC-supernatant (PRBC-SN; n=13) was prepared at weekly intervals throughout storage. Phospholipid-dependent procoagulant activity, assessed using a factor X-activated clotting time (XACT) assay, decreased throughout storage (p<0.0001), corresponding with increased procoagulant phospholipid content. As determined by flow cytometry, total numbers of MPs and of PS-bearing MPs increased by Day 28 of storage (p<0.01 and p<0.05, respectively, versus D1), and these MPs were predominantly RBC-derived (CD235+). Depletion of MPs from stored (Day 42) PRBC-SN using 0.22 μm filters reduced the number of PS-bearing MPs (p<0.01) but did not increase XACT clotting times. Furthermore, the reduction in procoagulant activity when lactadherin was used to block PS was not altered pre- or post-filtration of PRBC-SN. In conclusion, routine PRBC storage was associated with accumulation of MPs (particularly RBC-derived PS-bearing MPs) and of procoagulant phospholipids; however, depletion of PS-bearing MPs by 0.22 μm filtration did not reduce phospholipid-dependent procoagulant activity.

Keywords: Blood coagulation; blood transfusion; cell-derived microparticles; erythrocyte transfusion; phospholipids.

MeSH terms

  • Blood Coagulation / drug effects*
  • Blood Coagulation Tests / methods
  • Blood Preservation / methods*
  • Cell-Derived Microparticles*
  • Erythrocytes* / drug effects
  • Flow Cytometry / methods
  • Humans
  • Phosphatidylserines / pharmacology
  • Risk
  • Transfusion Reaction*

Substances

  • Phosphatidylserines